1-5 of 5
Kathrin Schönberg
Close
Sort by
Journal Articles

The JAK Inhibitor Ruxolitinib Substantially Affects NK Cells in MPN Patients

Kathrin Schönberg, PhD, Janna Rudolph, Maria Vonnahme, Isabelle Cornez, PhD, Sowmya Parampalli Yajnanarayana, Walter Verbeek, MD, Steffen Koschmieder, MD, Tim H. Brümmendorf, MD, Peter Brossart, MD, Annkristin Heine, MD, Dominik Wolf, MD
Journal: Blood
Blood (2014) 124 (21): 3169.
https://doi.org/10.1182/blood.V124.21.3169.3169
Published: 2014
Journal Articles

The JAK1/JAK2 Inhibitor Ruxolitinib Substantially Affects NK Cell Biology

Kathrin Schönberg, PhD, Janna Rudolph, Isabelle Cornez, PhD, Peter Brossart, MD, Dominik Wolf, MD
Journal: Blood
Blood (2013) 122 (21): 16.
https://doi.org/10.1182/blood.V122.21.16.16
Published: 2013
Journal Articles

Lack of association between KIR genes and acute lymphoblastic leukemia in children

Florian Babor, Angela Manser, Kathrin Schönberg, Jürgen Enczmann, Arndt Borkhardt, Roland Meisel, Markus Uhrberg
Journal: Blood
Blood (2012) 120 (13): 2770–2772.
https://doi.org/10.1182/blood-2012-07-440495
Published: 2012
Journal Articles

Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I

Brief Report
Kathrin Schönberg, Johannes C. Fischer, Gesine Kögler, Markus Uhrberg
Journal: Blood
Blood (2011) 117 (19): 5152–5156.
https://doi.org/10.1182/blood-2011-02-334441
Published: 2011
Journal Articles

Analyses of HLA-C–specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition

Kathrin Schönberg, Martina Sribar, Jürgen Enczmann, Johannes C. Fischer, Markus Uhrberg
Journal: Blood
Blood (2011) 117 (1): 98–107.
https://doi.org/10.1182/blood-2010-03-273656
Published: 2011
Includes: Supplemental data